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Hemodialysis access  
with an autologous tissue–
engineered vascular graft
McAllister et al., Lancet 2009; 373: 1440–1446; doi:10.1016/
S0140-6736(09)60248-8
Application of a tissue-engineered vascular graft for small-diam-
eter vascular reconstruction has been a long-awaited and much 
anticipated advance for vascular surgery. 
McAllister and co-workers now report on the high level of pat-
ency (78% at 1 month and 60% at 6 months) of tissue-engineered 
blood vessels used as access for hemodialysis. This remarkable 
accomplishment confirms the clinical usefulness of their biologi-
cal device described earlier by Conte.1 The study reports a 6-month 
follow-up for the first ten hemodialyzed patients implanted with a 
fully biological tissue-engineered graft, developed with cell-sheet 
tissue-engineering technology. The main advantage of the cell-
sheet technology seems to be related to the high cell density, which 
ensures synthesis and deposition of the proper amount of extracel-
lular matrix. The internal membrane was fabricated by the rolling 
of a monolayer of living fibroblast cells into a tubular tissue con-
struct. The maturated construct formed by the fused cell layers was 
then decellularized. The second concentric layer was fabricated by 
the rolling of a second monolayer of living fibroblast cells around 
the outside of the first tube. Finally, the tissue-engineered vascu-
lar tube—biofabricated from two concentric acellular and cellular 
layers—was seeded with autologous endothelial cells (Figure).2 
The development of aneurysms in some grafts after implantation 
can be explained either by suboptimal conditions for vascular-graft 
preservation during transportation or by the selection of fibro-
blasts as a cell source. Vascular grafts biofabricated from fibroblasts 
would have an insufficient amount of elastin and would be prone 
to aneurysm development due to collagen fatigue.3,4 The report 
states that switching to an allogeneic approach could address 
the key limitations associated with autologous cell–based tissue 
engineering, such as scale-up, production cost, and off-the-shelf 
availability. The successful clinical testing of the first commercial 
tissue-engineered vascular graft in hemodialysis patients is a revo-
lutionary milestone, manifesting the emergence of clinical vascular 
tissue engineering.
Marc De Broe
1FASEB J 1998; 12: 43–45. 2Lancet 2009; 373: 1402–1404. 3Expert Opin Biol Ther 
2008; 8: 143–152. 4Trends Biotechnol 2008; 26: 338–344.
Macrophages regulate  
blood pressure’s response to salt
Machnik et al., Nat Med 2009; 15: 545–552; doi:10.1038/nm.1960
Despite wide variability in the response to salt intake among sub-
jects, there is little doubt that more salt intake leads to higher blood 
pressure and greater incidence of hypertension among different 
populations. In addition, most monogenic forms of hypertension 
involve renal transporters that cause extracellular sodium reten-
tion. While the mechanism by which salt increases blood pressure 
remains unclear, the biological effects of a high-salt diet are of great 
interest given hypertension’s profound effect on cardiovascular 
disease and lifespan. Recent work on angiotensin II–dependent 
forms of experimental hypertension has revealed an unantici-
pated pathogenic role for leukocytes and T cells in this process. 
Mononuclear phagocyte system cells, including macrophages and 
Critical steps in the cell-sheet biofabrication technology of the  
tissue-engineered blood vessel from Cytograft Tissue Engineering’s 
vascular-graft system. 
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New format for Journal Club
The Journal Club feature has been very popular with readers and with authors 
whose work is featured. In one extreme case, when recently I was asked to write 
a letter of recommendation for an author’s promotion, I was taken aback to see 
that this author included his Journal Club in his resume as a sign of the article’s 
importance. The procedure we follow when choosing the articles for Journal Club 
is to have the Kidney International editors scan journals in their area of expertise 
to identify exciting articles to highlight. Generally, the abstract is rewritten with 
introductory and concluding statements that set the context in which the editor 
finds the paper interesting; these statements are sometimes different in focus 
from the author’s perspective. Also, in the past, the author’s name was placed 
within the summary and the reference placed after the summary; this format 
left ambiguity regarding what author and paper were being discussed. We now 
have a new, improved format that places the paper’s first author’s name and 
reference above the summary, right below the headline.
Another problem with Journal Club was that, in a few instances, the abstract 
of the original article was published with minimal changes using a KI editor’s 
name in the byline. This raised some concerns among the few people who 
noticed (largely the papers’ authors and their colleagues) about copyright 
infringement, authorship, and citation anomalies. This is not a trivial issue, as 
is exemplified by the fact that when I was showing a colleague how to analyze 
citations to his articles using my page in the ISI Web of Knowledge database, 
the Journal Clubs I wrote were listed as my publications! Fortunately, when the 
abstracts are rewritten, the KI editors are indeed the actual authors. Therefore, 
going forward, all of the Journal Club summaries will be written entirely by 
the editors, although they will contain some wording from the abstracts. We 
apologize to the authors of papers used in Journal Club for these unintended 
slips in formatting and writing. We promise to turn over any paperback and 
movie rights for these summaries when Hollywood comes calling.
Qais Al-Awqati
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(GBCAs) in causing the disease has grown as a result of recent 
studies. However, the pathophysiological processes that may lead 
to NSF remain uncertain. The authors of a new study examined the 
mechanisms of fibrotic skin changes using a recently published rat 
model of NSF. They investigated serum markers of inflammation. 
Male Wistar rats were treated once, three times, or eight times 
with intravenous injections of 2.5 mmol/kg gadodiamide daily. The 
authors conducted an analysis of 70 protein serum markers and 
noted clinical observations, hematology, clinical pathology, and 
histopathology, including electron microscopy and gadolinium 
in serum, skin, femur, and liver tissue. Gadolinium was found in 
the skin, femur, and liver of the gadodiamide-treated rats 6 hours 
after the first injection. Macroscopic skin changes in the form of 
reddening and early scab formation were seen in one animal after 
the third daily administration and in all animals after eight daily 
administrations (Figure). Dermal infiltrations were found after 
three administrations, which led to inflammatory lesions, ulcera-
tions, and crusts. A total of 13 cytokines were significantly elevated 
6 hours after the first injection, and 8 remained elevated: monocyte 
chemotactic protein-1 (MCP-1) and MCP-3, macrophage inflam-
matory protein-1β (MIP-1β) and MIP-2, tumor necrosis factor-α 
(TNF-α), the extracellular matrix regulator tissue inhibitor of 
metalloproteinase type 1 (TIMP-1), osteopontin, and vascular 
endothelial growth factor–C (VEGF-C). This latter finding is of 
particular interest because VEGF is involved in the regulation of 
dystrophic calcification and plays a role as a chemoattractant for 
dendritic cells, macrophages, and T lymphocytes, which activate 
inflammatory pathways. On the basis of these findings, the authors 
hypothesize that gadolinium released from the GBCA complex 
forms insoluble gadolinium deposits, which then cause a physi-
ological response similar to that seen during dystrophic calcifica-
tion, that is, an upregulation of osteopontin and chemoattractant 
cytokines. The simultaneous increase in vascular permeability 
caused by MIP-1, TNF-α, and VEGF may lead to extravasation 
of chelated gadolinium or gadolinium deposits. Further, the per-
sistence of the gadolinium deposits could cause proinflammatory 
pathways to overreact, thus causing the visual skin abrasions. 
Finally, the authors’ intriguing arguments suggest a potential role 
for osteopontin in the development of NSF.
Marc De Broe
dendritic cells, regulate various homeostatic processes, including 
lymphan giogenesis. The important role of the lymphatic network in 
extracellular fluid control has long been appreciated. In an elegant 
new study, Machnik et al. examine the effects of a high-salt diet on 
mononuclear phagocyte cells. High salt in rats led to interstitial 
hypertonic sodium (Na+) accumulation in the skin, increasing the 
density and hyperplasia of the lymphatic capillary network. The 
mechanisms underlying the effect on lymphatics include activation 
of tonicity-responsive enhancer binding protein (TonEBP) in the 
mononuclear phagocyte cells infiltrating the interstitium of the skin. 
TonEBP/NFAT5 is a transcription factor involved in many cellular 
responses, including response to osmotic stress, integrin-depend-
ent cell migration, and T-cell activation. Needless to say, it plays a 
critical role in urinary concentration and kidney papillary develop-
ment. The authors found that TonEBP binds the promoter of the 
gene encoding vascular endothelial growth factor–C (VEGF-C) 
and causes VEGF-C secretion by macrophages, hence increas-
ing lymphatic growth. Thus, high-salt feeding led to a hypertonic 
interstitium, at least in the skin, which, via mononuclear phagocyte 
cell activation, led to VEGF-C secretion, lymph capillary network 
hyperplasia, and increased expression of endothelial nitric oxide 
synthase. Conversely, depletion of mononuclear phagocyte cells 
or VEGF-C blockade augmented interstitial hypertonic volume 
retention, decreased endothelial nitric oxide synthase, and elevated 
blood pressure in response to the high-salt diet. These provocative 
results indicate that TonEBP–VEGF-C signaling in mononuclear 
phagocyte cells is an important determinant of extracellular volume 
and blood pressure regulation. Intriguingly, plasma VEGF-C was 
increased in patients with refractory hypertension (Figure). The 
authors thus identified Vegfc as an osmosensitive gene involved 
in salt-induced hypertension. These studies indicate that the lym-
phatic capillary network plays a role not only in extracellular fluid 
control but also in sodium balance and blood pressure.
Juan Oliver
Proinflammatory cytokines  
in nephrogenic systemic fibrosis
Steger-Hartmann et al., Exp Toxicol Pathol advance online publication,  
6 January 2009, doi:10.1016/j.etp.2008.11.004
Nephrogenic systemic fibrosis (NSF) is a rare but serious disease 
that takes place in patients with severe or end-stage renal disease. 
Evidence for the involvement of gadolinium-based contrast agents 
VEGF-C serum concentrations in normotensive control subjects and in 
subjects with refractory hypertension. 
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Argyrophilic structures in skin of rats after eight administrations of 
2.5 mmol/kg gadodiamide: in the area of ulceration (top), thick black 
staining (dystrophic calcification); in the dermis, delicate stained fibers  
(von Kossa stain).
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